We are live on
!
Find out more
Syndax Pharmaceuticals
SNDX
SNDX
83 hedge funds and large institutions have $228M invested in Syndax Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 27 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
2,657% more call options, than puts
Call options by funds: $6.23M | Put options by funds: $226K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 11
56% more capital invested
Capital invested by funds: $146M → $228M (+$81.4M)
15% more funds holding
Funds holding: 72 → 83 (+11)
7.24% more ownership
Funds ownership: 61.44% → 68.68% (+7.2%)
8% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 25
Holders
83
Holders Change
+11
Holders Change %
+15.28%
% of All Funds
1.83%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
22
Increased
27
Reduced
25
Closed
11
Calls
$6.23M
Puts
$226K
Net Calls
+$6M
Net Calls Change
+$3.63M
Top Buyers
| 1 |
FM
Frazier Management
Seattle,
Washington
|
+$9.3M |
| 2 |
ACM
Aisling Capital Management
New York
|
+$8.21M |
| 3 |
BlackRock
New York
|
+$6.51M |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$4.46M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$3.52M |
